Christopher Shea to Melanocytes
This is a "connection" page, showing publications Christopher Shea has written about Melanocytes.
Connection Strength
3.308
-
Grading Melanocytic Dysplasia: Updated Histopathologic Criteria. J Cutan Pathol. 2026 Jan; 53(1):29-37.
Score: 0.867
-
Melanocytic tumors with intraepidermal melanophages: a report of five cases with review of 231 archived cutaneous melanocytic tumors. J Cutan Pathol. 2015 Jun; 42(6):394-9.
Score: 0.445
-
Melanocytes, melanocyte stem cells, and melanoma stem cells. Clin Dermatol. 2013 Mar-Apr; 31(2):166-78.
Score: 0.385
-
Use of immunohistochemistry in melanocytic lesions. J Cutan Pathol. 2008 Nov; 35 Suppl 2:1-10.
Score: 0.285
-
Recent developments in the pathology of melanocytic neoplasia. Dermatol Clin. 1999 Jul; 17(3):615-30, ix.
Score: 0.149
-
Correlating architectural disorder and cytologic atypia in Clark (dysplastic) melanocytic nevi. Hum Pathol. 1999 May; 30(5):500-5.
Score: 0.148
-
The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis. J Invest Dermatol. 1998 Aug; 111(2):233-8.
Score: 0.140
-
Numbers and differentiation status of melanocytes in idiopathic guttate hypomelanosis. J Cutan Pathol. 1998 Aug; 25(7):375-9.
Score: 0.140
-
Cellular Blue Nevomelanocytic Lesions: Analysis of Clinical, Histological, and Outcome Data in 37 Cases. Am J Dermatopathol. 2016 Jul; 38(7):499-503.
Score: 0.121
-
Evaluation of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) classification scheme for diagnosis of cutaneous melanocytic neoplasms: Results from the International Melanoma Pathology Study Group. J Am Acad Dermatol. 2016 Aug; 75(2):356-63.
Score: 0.120
-
KIT expression reveals a population of precursor melanocytes in human skin. J Invest Dermatol. 1996 May; 106(5):967-71.
Score: 0.120
-
Diameter of dysplastic nevi is a more robust biomarker of increased melanoma risk than degree of histologic dysplasia: a case-control study. J Am Acad Dermatol. 2014 Dec; 71(6):1257-1258.e4.
Score: 0.108
-
Shifts in Cutaneous Melanocytic Tumor Diagnostic Terminology: Melanocytoma, MPATH-Dx V2.0 and the WHO Skin5. J Cutan Pathol. 2026 Jan; 53(1):91-100.
Score: 0.056
-
Pagetoid melanocytosis: when is it significant? Pathology. 2004 Oct; 36(5):435-44.
Score: 0.054
-
Maturing papillomatous nevoid melanoma in the scalp mimicking recurrent melanocytic nevus: A case report of previously undescribed subtype of nevoid melanoma. Pathol Int. 2022 Jan; 72(1):59-64.
Score: 0.044
-
Recurrent melanocytic nevus: a histologic and immunohistochemical evaluation. J Cutan Pathol. 2001 Sep; 28(8):400-6.
Score: 0.043
-
Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res. 1995 Jul 01; 55(13):2713-8.
Score: 0.028
-
Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma. J Cutan Pathol. 2015 Apr; 42(4):244-52.
Score: 0.028
-
Decreased CD117 expression in hypopigmented mycosis fungoides correlates with hypomelanosis: lessons learned from vitiligo. Mod Pathol. 2006 Sep; 19(9):1255-60.
Score: 0.015
-
p53 expression is rare in cutaneous melanomas. Am J Dermatopathol. 1995 Aug; 17(4):344-9.
Score: 0.007
-
Visible action spectrum for melanin-specific selective photothermolysis. Lasers Surg Med. 1989; 9(4):389-97.
Score: 0.005